000 | 01463 a2200421 4500 | ||
---|---|---|---|
005 | 20250516062622.0 | ||
264 | 0 | _c20120322 | |
008 | 201203s 0 0 eng d | ||
022 | _a1502-7732 | ||
024 | 7 |
_a10.3109/03009742.2011.610032 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHesselstrand, R | |
245 | 0 | 0 |
_aScleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor. _h[electronic resource] |
260 |
_bScandinavian journal of rheumatology _cFeb 2012 |
||
300 |
_a39-43 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xphysiopathology |
650 | 0 | 4 |
_aKidney Diseases _xetiology |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aRNA Polymerase III _ximmunology |
650 | 0 | 4 | _aRenal Dialysis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aScleroderma, Systemic _ximmunology |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aSweden |
700 | 1 | _aScheja, A | |
700 | 1 | _aWuttge, D M | |
773 | 0 |
_tScandinavian journal of rheumatology _gvol. 41 _gno. 1 _gp. 39-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/03009742.2011.610032 _zAvailable from publisher's website |
999 |
_c21274556 _d21274556 |